2022 annual financial data
Boundless Bio, Inc. 2022 Operating margin
Boundless Bio, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -46,469,000 USD and net income was -45,901,000 USD.
Operating cash flow was -39,596,000 USD.
Get free Boundless Bio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -46,469,000 USD
- Net income
- -45,901,000 USD
- Operating cash flow
- -39,596,000 USD